{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:32:38Z","timestamp":1789011158031,"version":"build-2803163510"},"reference-count":119,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The main challenges in the treatment of T\u2010cell lymphoblastic lymphoma (T\u2010<jats:styled-content style=\"fixed-case\">LBL<\/jats:styled-content>) in children and adolescents are twofold: to increase survival rates in concert with reduction of acute and long\u2010term toxicities including the rate of secondary malignancies. The need for molecular and prognostic markers in T\u2010<jats:styled-content style=\"fixed-case\">LBL<\/jats:styled-content> is crucial to allow for systematic treatment optimization and may serve as targets for new treatment approaches.<\/jats:p>","DOI":"10.1111\/bjh.14017","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:52:57Z","timestamp":1458348777000},"page":"545-559","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Current status and future directions of T\u2010lymphoblastic lymphoma in children and adolescents"],"prefix":"10.1111","volume":"173","author":[{"given":"Birgit","family":"Burkhardt","sequence":"first","affiliation":[{"name":"Paediatric Haematology and Oncology University Hospital Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Mueller","sequence":"additional","affiliation":[{"name":"Paediatric Haematology and Oncology University Hospital Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem","family":"Khanam","sequence":"additional","affiliation":[{"name":"Paediatric Haematology and Oncology University Hospital Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Utah Health Sciences Center, ARUP Institute for Clinical and Experimental Pathology Salt Lake City Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07320.x"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2304"},{"key":"e_1_2_11_4_1","volume-title":"SEER Cancer Statistics Review 1975\u20102007","author":"Altekruse S.F.","year":"2010"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(200003)34:3<200::AID-MPO7>3.0.CO;2-T"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401310"},{"key":"e_1_2_11_7_1","first-page":"747","article-title":"Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia","volume":"88","author":"Arico M.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-292615"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.10.013"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25553"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.203"},{"key":"e_1_2_11_12_1","first-page":"692","article-title":"T cell receptor genotyping and HOXA\/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome","volume":"14","author":"Baleydier F.","year":"2008","journal-title":"ClinicalCancer Research"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.073585"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-013-9676-3"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20924"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25699"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08863.x"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-474148"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13105"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-4956"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20244"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08006.x"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05735.x"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2707"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404275"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701824551"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.3367"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.7661"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015511"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.205"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2006-0017"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70314-0"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1318"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.8724"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0322"},{"key":"e_1_2_11_36_1","first-page":"606","article-title":"Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) of Chromosme 6q16\u201021 Identifies a Prognostically Poor Group of Childhood and Adult T Cell Acute Lymphoblastic Leukemia (ALL) Patients","volume":"102","author":"Foroni L.","year":"2003","journal-title":"Blood"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24848"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1142\/9789814299619_0001"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-2-10"},{"key":"e_1_2_11_40_1","first-page":"1079","article-title":"T\u2010immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study.","volume":"88","author":"Giordano P.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2013.01.004"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.09.021"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3283623c61"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009148394"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1101098"},{"key":"e_1_2_11_46_1","first-page":"138","article-title":"Clinical features and prognosis of children with lymphoblastic lymphoma","volume":"34","author":"Jin L.","year":"2012","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208186"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311969"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22076"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209234200"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21037"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0659-z"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1585-z"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.203"},{"key":"e_1_2_11_55_1","volume-title":"3rd International Symposium on Childhood, adolescent and young adult Non\u2010Hodgkin's Lymphoma","author":"Landmann E.","year":"2009"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29685"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03702"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402640"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.18.3262"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70274-7"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(03)00048-0"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5827"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21941"},{"key":"e_1_2_11_64_1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V114.22.990.990","article-title":"Prospective Evaluation of Thromboembolic Events During Chemotherapy of Childhood Acute Lymphoblastic Leukemia: Results of Randomized Trial ALL\u2010BFM 2000","volume":"114","author":"M\u00f6ricke A.","year":"2009","journal-title":"Blood"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0939-7"},{"key":"e_1_2_11_66_1","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non\u2010Hodgkin's lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy S.B.","year":"1980","journal-title":"Seminars in Oncology"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.134"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e318238f72b"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/11.suppl_1.S63"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001683679"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070876"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030809"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07607.x"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12042"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12882"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950200204"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403272"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22162"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25469"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14666"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20550"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12733"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.359"},{"key":"e_1_2_11_84_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_11_85_1","first-page":"38","article-title":"Results of the European intergroup trial EURO\u2010LB02 on lymphoblastic lymphoma (LBL) in children\/adolescents","volume":"159","author":"Reiter A.","year":"2012","journal-title":"British Journal of Haematology"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1276-9"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e328334fc14"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701344899"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7203"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.400"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0745"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e31828dc614"},{"key":"e_1_2_11_93_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0889-8588(18)30396-4","article-title":"Non\u2010Hodgkin's lymphomas in Asia","volume":"5","author":"Shih L.Y.","year":"1991","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245951"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-013-1993-8"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70198-0"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21823"},{"key":"e_1_2_11_99_1","first-page":"33","article-title":"Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I\u2010BFM LL 09 protocol","volume":"171","author":"Sterba J.","year":"2015","journal-title":"British Journal of Haematology"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0771-5"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25824"},{"key":"e_1_2_11_102_1","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"Swerdlow S.H.","year":"2008"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24149"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12460"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5292"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1368"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.02.011"},{"key":"e_1_2_11_108_1","first-page":"37","article-title":"Dexamethasone (DEX) versus prednisone (PRED) in T\u2010cell non Hodgkin lymphoma (T\u2010NHL): results of the randomized phase III trial 58951 of the EORTC Children Leukemia Group","volume":"159","author":"Uyttebroeck A.","year":"2012","journal-title":"British Journal of Haematology"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2015.05.005"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.2070"},{"key":"e_1_2_11_111_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood.V106.11.232.232","article-title":"Secondary neoplasms subsequent to Berlin\u2010Frankfurt\u2010Muenster (BFM) therapy of Non\u2010Hodgkin lymphoma of childhood: significantly higher risk for patients with lymphoblastic lymphoma compared to other NHL\u2010subtypes","volume":"106","author":"Wachowski O.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102284"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3217"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25470"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<123::AID-CNCR2820370119>3.0.CO;2-7"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197912)44:6<1990::AID-CNCR2820440605>3.0.CO;2-9"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24021"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201202500309"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPMF03LVSBLHPJ"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.204"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.14017","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.14017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T14:05:36Z","timestamp":1694527536000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.14017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1111\/bjh.14017"],"URL":"https:\/\/doi.org\/10.1111\/bjh.14017","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]},"assertion":[{"value":"2015-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}